Clinical Trials Browser

OTHER × Ovarian Neoplasms × Imatinib Mesylate × Clear all

NCT00216112 2016-02-19

Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms

NCT00510653 2013-08-23

Gleevec Study for Patients With Ovarian Cancer

Phase 2 Completed

73 enrolled 4 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00840450 2012-11-19

Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin

Phase 2 Terminated

14 enrolled 10 charts

Ovarian Neoplasms, Recurrence